Abstract
Background: Tuberculosis caused by Mycobacterium tuberculosis (MTB) is currently a major health concern due to its growing mortality rates around the world. The known anti-TB drugs although are available for the treatment but it produces adverse side effects on the human health and are also not very cost effective. Moreover, emergence of multidrug resistance (MDR) phenomenon has also compromised their activities.
Objective: Hence there is an urgent need to search novel drugs and compounds from natural sources having lesser side effects which have proved to be vital and widely used nowadays. Many recent studies have been established which show promising antimycobacterial activities against MTB.
Result: This review summarizes the various naturally occurring active compounds acting on different targets against MTB. Moreover, it also deals with the compounds having patent perspective.
Conclusion: Together, the article laid emphasis on reverting towards the natural compounds so that further work is carried out to exploit their therapeutic interventions.
Keywords: Mycobacterium tuberculosis, MDR, Natural compound, antimycobacterial activity, efflux pump, cell wall.
Recent Patents on Biotechnology
Title:Natural Compounds for Overcoming Multidrug Resistance in Mycobacteria
Volume: 10 Issue: 2
Author(s): Sharda Sharma, Saif Hameed and Zeeshan Fatima
Affiliation:
Keywords: Mycobacterium tuberculosis, MDR, Natural compound, antimycobacterial activity, efflux pump, cell wall.
Abstract: Background: Tuberculosis caused by Mycobacterium tuberculosis (MTB) is currently a major health concern due to its growing mortality rates around the world. The known anti-TB drugs although are available for the treatment but it produces adverse side effects on the human health and are also not very cost effective. Moreover, emergence of multidrug resistance (MDR) phenomenon has also compromised their activities.
Objective: Hence there is an urgent need to search novel drugs and compounds from natural sources having lesser side effects which have proved to be vital and widely used nowadays. Many recent studies have been established which show promising antimycobacterial activities against MTB.
Result: This review summarizes the various naturally occurring active compounds acting on different targets against MTB. Moreover, it also deals with the compounds having patent perspective.
Conclusion: Together, the article laid emphasis on reverting towards the natural compounds so that further work is carried out to exploit their therapeutic interventions.
Export Options
About this article
Cite this article as:
Sharma Sharda, Hameed Saif and Fatima Zeeshan, Natural Compounds for Overcoming Multidrug Resistance in Mycobacteria, Recent Patents on Biotechnology 2016; 10 (2) . https://dx.doi.org/10.2174/1872208310666160919122629
DOI https://dx.doi.org/10.2174/1872208310666160919122629 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Modulation of Proinflammatory Bacteria- and Lipid-Coupled Intracellular Signaling Pathways in a Transwell Triple Co-Culture Model by Commensal Bifidobacterium Animalis R101-8
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry NAD in Skin: Therapeutic Approaches for Niacin
Current Pharmaceutical Design Vitamin D Intervention Trials in Critical Illness
Inflammation & Allergy - Drug Targets (Discontinued) Modern Drug Discovery Technologies: Opportunities and Challenges in Lead Discovery
Combinatorial Chemistry & High Throughput Screening Biomarkers of Asthma: Recent Patents from 2009-2011
Recent Patents on Biomarkers Antimicrobial Peptides with pH-Dependent Activity and Alkaline Optima: Their Origins, Mechanisms of Action and Potential Applications
Current Protein & Peptide Science Aorta Remodeling Due to Stretch or Turbulent Flow/Low Wall Shear Stress: Distinctly Different Biological Phenomena?
Current Cardiology Reviews Computational Evidence for the Reactivation Process of Human Acetylcholinesterase Inhibited by Carbamates
Combinatorial Chemistry & High Throughput Screening Modifier Gene Studies to Identify New Therapeutic Targets in Cystic Fibrosis
Current Pharmaceutical Design 4-Aryl-1,4-Dihydropyridines as Potential Enoyl-Acyl Carrier Protein Reductase Inhibitors: Antitubercular Activity and Molecular Docking Study
Current Topics in Medicinal Chemistry Prevalence of Dilated Cardiomyopathy in HIV-Infected African Patients Not Receiving HAART: A Multicenter, Observational, Prospective, Cohort Study in Rwanda
Current HIV Research Can Probiotics Cure Inflammatory Bowel Diseases?
Current Pharmaceutical Design Treating Nonthyroidal Illness Syndrome in the Critically Ill Patient: Still a Matter of Controversy
Current Drug Targets Chemotherapeutic Strategies Against Trypanosoma brucei: Drug Targets vs. Drug Targeting
Current Pharmaceutical Design Recent Advancement in the Diagnosis and Treatment of Leprosy
Current Topics in Medicinal Chemistry Copper (II) – HisAibGly Complex and Its Superoxide Dismutase Activity (Suplementary Material)
Protein & Peptide Letters Patients Characteristics and Clinical Implications of Suboptimal CD4 T-Cell Gains After 1 Year of Successful Antiretroviral Therapy
Current HIV Research Graphical Abstracts
Medicinal Chemistry Recent Advances in Design of Glycogen Phosphorylase Inhibitors
Current Enzyme Inhibition Ascaris lumbricoides: An Overview of Therapeutic Targets
Infectious Disorders - Drug Targets